Ocular Therapeutix, Inc. (OCUL)
9.06
-0.10
(-1.09%)
USD |
NASDAQ |
Feb 12, 16:00
9.18
+0.12
(+1.32%)
After-Hours: 20:00
Ocular Therapeutix Cash from Investing (Quarterly) : -2.839M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
| Bristol Myers Squibb Co. | -- |
| Krystal Biotech, Inc. | -4.286M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -54.25M |
| Cash from Financing (Quarterly) | 449.38M |
| Free Cash Flow | -216.89M |
| Free Cash Flow Per Share (Quarterly) | -0.2561 |
| Free Cash Flow to Equity (Quarterly) | -57.05M |
| Free Cash Flow to Firm (Quarterly) | -54.26M |
| Free Cash Flow Yield | -12.79% |